Together, these findings have provoked important questions not only about the cellular sources and targets of type I IFNs but also about the triggers and the causative series of events that eventually foster IFN production and B cell activation, respectively, in patients with SLE. Here, IFNA1 is linked to systemic lupus erythematosus.